Zinc oxide, <100 nm particle size

Name: Zinc oxide, <100 nm particle size
Brand: MedChemExpress
SKU: HY-W116336D
Rating: 4.5 (0 reviews)

製品番号: HY-W116336D Assay: 99.28%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Zinc oxide, <100 nm particle size is a nitrate reductase modulator and growth promoter with plant stress resistance activity and oral toxicity. Zinc oxide, <100 nm particle size acts as a nutrient source for maize plants. By enhancing nitrate reductase activity and reducing free proline levels, it significantly improves plant height, root length and dry matter weight of maize, and its growth-promoting effect is comparable to that of traditional zinc sulfate fertilizer. Zinc oxide, <100 nm particle size induces anemia-related and persistent tissue inflammatory damage, leading to obvious histopathological adverse reactions in the stomach, pancreas, eyes and prostate of rats. Zinc oxide, <100 nm particle size acts as a non-toxic antibacterial agent and selective cytotoxin against multiple bacteria, fungi and spores.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Zinc oxide, <100 nm particle size 構造式

CAS 番号 : 1314-13-2

容量	価格（税別）	在庫状況	数量
50 mg	$25	在庫あり	Estimated Time of Arrival: December 31
100 mg	$35	在庫あり	Estimated Time of Arrival: December 31
500 mg	$55	在庫あり	Estimated Time of Arrival: December 31
1 g	$75	在庫あり	Estimated Time of Arrival: December 31
5 g	$120	在庫あり	Estimated Time of Arrival: December 31
10 g	$170	在庫あり	Estimated Time of Arrival: December 31
50 g		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

おすすめ

•関連小分子:

•関連タンパク質:

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

体外実験

Zinc oxide, <100 nm particle size (30 min dispersion; measured at 23°C for particle size, 25°C for zeta potential) has a zeta potential of -26.99 mV, agglomerates readily after dispersion, and maintains a <100 nm size as visualized via TEM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Zinc oxide, <100 nm particle size (0.05-0.5 ppm; in vitro nutrient solution; continuous exposure; 3 weeks) enhances maize plant growth, biomass production, nitrate reductase activity, and zinc accumulation in a dose-dependent manner, with the 0.5 ppm dose producing the greatest improvements^[1].
Repeated oral administration of <100 nm zinc oxide nanoparticles (both negatively and positively charged) (31.25-500 mg/kg; p.o.; daily/once daily, 7 days/week; 14-90 days) at doses ≥125 mg/kg for 90 days induces significant toxic effects in Sprague Dawley rats, with target organs including the stomach, pancreas, eye, and prostate gland, and a no observed adverse effect level (NOAEL) of 31.25 mg/kg for both sexes^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Crl:CD(SD) rats (6-week-old, both sexes, 145.8-196.1 g, specific pathogen-free)^[2]
Dosage:	For 90-day DRF study: 500 mg/kg, 1000 mg/kg, 2000 mg/kg For 14-day DRF study: 31.25 mg/kg, 125 mg/kg, 500 mg/kg
Administration:	I:p.o.; daily; 14 days II: p.o.; once daily, 7 days/week; 90 days
Result:	Reported one death in the positively charged 1000 mg/kg group in the 14-day DRF study. Observed white feces, body weight loss, and corneal opacity across all doses in the 14-day DRF study. Noted histopathological lesions in the stomach and spleen in the 14-day DRF study. Recorded no mortality at any dose in the 90-day study. Observed sporadic salivation, white feces (consistent in 500 mg/kg groups), fur loss, and scarring across all doses in the 90-day study. Detected statistically significant, non-toxic feed and water consumption changes across doses in the 90-day study due to lack of dose dependency. Measured decreased hemoglobin, mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), hematocrit, and increased eosinophil counts in 500 mg/kg groups (both charges) in the 90-day study. Recorded decreased total erythrocyte count and prothrombin time in male 500 mg/kg groups, and increased total white blood cell and platelet counts in female 500 mg/kg groups in the 90-day study. Measured decreased total protein, albumin, and glucose; increased alkaline phosphatase, chloride, and inorganic phosphorus (males only) in 500 mg/kg groups (both charges) in the 90-day study. Recorded decreased total cholesterol and calcium, and increased creatine kinase in female 500 mg/kg groups in the 90-day study. Observed dose-dependent histopathological lesions at 500 mg/kg (some present at lower doses) including squamous cell hyperplasia/vacuolation (nonglandular stomach), intracytoplasmic hyaline droplets, submucosal edema/inflammation, eosinophilic chief cell/mucous cell hyperplasia (glandular stomach), acinar cell apoptosis/chronic inflammation (pancreas), retinal atrophy (eye), and suppurative inflammation (prostate gland, males) in the 90-day study. Measured increased submandibular gland weight (female 500 mg/kg negatively charged group), increased liver weight (female 500 mg/kg positively charged group), and increased relative adrenal gland weight/decreased absolute spleen weight (male 500 mg/kg positively charged recovery group) in the 90-day study.

分子量

81.38

分子式

ZnO

CAS 番号

1314-13-2

Appearance

Solid

Color

White to off-white

SMILES

[Zn]=O

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Store at room temperature, keep dry and cool

*In solvent : -80°C, 6 months; -20°C, 1 month (Store at room temperature, keep dry and cool)

純度とドキュメンテーション

純度: 99.28%

Select Batch:

データシート (278 KB) SDS (458 KB)

COA (254 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Adhikari T, et al. Characterization of zinc oxide nano particles and their effect on growth of maize (Zea mays L.) plant[J]. Journal of Plant Nutrition, 2015, 38(10): 1505-1515.

[2]. Kim YR, et al. Toxicity of 100 nm zinc oxide nanoparticles: a report of 90-day repeated oral administration in Sprague Dawley rats. Int J Nanomedicine. 2014;9 Suppl 2(Suppl 2):109-126. Published 2014 Dec 15. [Content Brief]

[3]. Shamhari MN, et al. Synthesis and Characterization of Zinc Oxide Nanoparticles with Small Particle Size Distribution. Acta Chim Slov. 2018;65(3):578-585. [Content Brief]